62.45DKK-0.08%Mkt Cap: 16.54B DKKP/E: 34.89Last update: 2026-05-13
Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, includin…
Industry Peers
Medical Devices51.51BSEKP/E 21.8
49.73BDKKP/E 21.1
49.36BSEKP/E 91.5
37.38BEURP/E 17.7
21.21BSEK—
20.79BEURP/E 21.8
14.09BSEK—
13.76BDKKP/E 52.5
loading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)34.89
P/E (Forward)20.26
PEG2.85
P/B2.69
P/S2.71
EV/EBITDA20.08
EV/Revenue2.67
EPS (TTM)1.79
EPS (Forward)3.08
Cash Flow & Leverage
FCF Yield1.70%
FCF Margin4.61%
Operating CF813.00M DKK
CapEx (TTM)289.00M DKK
Net Debt/EBITDA-0.17
Net Debt-140.00M DKK
Technical
SMA 5067.23 (-7.1%)
SMA 20085.22 (-26.7%)
Beta1.26
S&P 52W Chg24.23%
Avg Vol (30d)1.13M
Avg Vol (10d)1.68M
Technical Indicators
RSI (14)38.2
MACD-1.8525
MACD Signal-1.8512
MACD Hist.-0.0013
BB Upper70.76 DKK
BB Middle65.08 DKK
BB Lower59.40 DKK
BB Width17.45%
ATR (14)2.212 DKK
Vol Ratio (20d)0.72x
52W Range
60.454% of range111.80
52W High111.80 DKK
52W Low60.45 DKK
Profitability
Gross Margin59.38%
EBITDA Margin13.29%
Profit Margin4.36%
Oper. Margin11.00%
ROE4.20%
ROA3.28%
Revenue Growth1.20%
Earnings Growth-35.20%
Balance Sheet
Debt/Equity0.10
Current Ratio2.92
Quick Ratio1.62
Book Value/Sh23.19 DKK
Cash/Share2.627 DKK
Dividends
Fwd Div Rate0.4100 DKK
Trail. Div Rate0.4100 DKK
Div. Yield0.66%
5Y Avg Yield0.24%
Payout Ratio22.91%
Ex-Div DateDec 4, 2025
Pay Date—
Splits
Last Split5:1
Split DateJan 3, 2018
Ownership
Shares Out.230.46M
Float181.44M
Insiders41.21%
Institutions32.91%
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)88.80 DKK
Target Range65.00 DKK – 116.40 DKK
# Analysts8
Company
Market Cap16.54B DKK
Enterprise Value16.29B DKK
Revenue (TTM)6.10B DKK
Gross Profit3.20B DKK
Net Income (TTM)235.00M DKK
Revenue/Share22.96 DKK
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees5.2K
Last Price62.45 DKK
CountryDK
SectorHealthcare
IndustryMedical Devices
ISIN—